Major histocompatibility complex class II molecules present peptides to CD4+ T cells. New findings indicate that conventional and plasmacytoid dendritic cells handle these molecules differently after activation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Young, L.J. et al. Nat. Immunol. 9, 1224–1252 (2008).
Bartee, E. et al. J. Virol. 78, 1109–1120 (2004).
Matsuki, Y. et al. EMBO J. 26, 846–854 (2007).
De Gassart, A. et al. Proc. Natl. Acad. Sci. USA 105, 3491–3496 (2008).
Shin, J.S. et al. Nature 444, 115–1118 (2006).
van Niel, G. et al. Immunity 25, 885–894 (2006).
Thibodeau, J. et al. Eur. J. Immunol. 38, 1225–1230 (2008).
Ohmura-Hoshino, M. et al. J. Immunol. 177, 341–354 (2006).
Arndt, S.O. et al. EMBO J. 19, 1241–1251 (2000).
Zwart, W. et al. Immunity 22, 221–223 (2005).
Pierre, P. et al. Nature 388, 787–792 (1997).
Cella, M. et al. Nature 388, 782–787 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van den Hoorn, T., Neefjes, J. Activated pDCs: open to new antigen-presentation possibilities. Nat Immunol 9, 1208–1210 (2008). https://doi.org/10.1038/ni1108-1208
Issue Date:
DOI: https://doi.org/10.1038/ni1108-1208
